Categories AlphaGraphs, Earnings, Health Care
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the first quarter of 2024. The company reported a net income for Q1, compared to a loss last year.
Trxade reported a net income of $21.25 million for the three months ended March 31, 2024, compared to a loss of $0.68 million in the corresponding period of the prior fiscal year. On a per-share basis, it was a loss of $6.40 in the first quarter, compared to a loss of $1.69 per share in the prior-year quarter.
Net income from discontinued operations, related to divestitures, was $27.88 million. The company did not generate any revenues during the quarter.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
What to expect when Conagra Brands (CAG) reports its Q4 2024 earnings results
Shares of Conagra Brands, Inc. (NYSE: CAG) stayed green on Monday. The stock has dropped 4% over the past one month. The branded foods company is scheduled to report its
Earnings Preview: PepsiCo’s Q2 results likely to reflect brand power, innovation
While the business world struggles to come out from the grip of inflation, some sectors have managed to stay resilient and the beverage industry is one of them. PepsiCo, Inc.
After first-ever stock split, where’s Chipotle Mexican Grill headed?
Chipotle Mexican Grill, Inc. (NYSE: CMG) has long been a favorite brand among both diners and investors, as the restaurant chain serves quality food while consistently delivering sales and earnings
